# Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

> **NCT03843580** · NA · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 80 (actual)

## Conditions studied

- Apnea, Postanesthetic
- Desaturation of Blood
- Apnea
- Anesthesia
- Larynx Disease
- Pharynx; Anomaly

## Interventions

- **DEVICE:** optiflow

## Key facts

- **NCT ID:** NCT03843580
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-23
- **Primary completion:** 2021-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843580, "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03843580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*